Eculizumab, a C5 inhibitor is largely used in ab-mediated disease like severe resistant lupus nephritis [61] or neuromyelitis optica [62] and has already successfully treated patients, At the time of writing this review, one molecule has been tested in IMNM: zilucoplan. The gene discussed is C5; the disease is neuromyelitis optica.